0

Chemo Plus Atezolizumab Shows Improved Survival Benefits in SCLC

By May 2, 2024
Current Status
Not Enrolled
Price
Free
Get Started

This courses discusses how the outcome of the combination regimen of chemotherapy and atezolizumab and subsequent treatment sequences upon patients with extensive-stage small call lung cancer (SCLC).